Oncolytics Biotech buy El_Zocko
Start price
27.02.15
/
50%
€6.75
Target price
16.06.15
€19.00
Performance (%)
-27.75%
End price
16.06.15
€4.87
Summary
This prediction ended on 16.06.15 with a price of €4.87. The price of Oncolytics Biotech has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.75%. El_Zocko has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oncolytics Biotech | - | - | - | - |
| iShares Core DAX® | -2,12 % | -8,18 % | -1,47 % | 54,14 % |
| iShares Nasdaq 100 | -1,13 % | 0,91 % | 19,96 % | 83,32 % |
| iShares Nikkei 225® | -0,66 % | -6,26 % | 27,47 % | 53,61 % |
| iShares S&P 500 | -1,26 % | -1,00 % | 13,63 % | 62,62 % |
Comments by El_Zocko for this prediction
In the thread Oncolytics Biotech diskutieren
Runde 2 im Zock - ONCOLYTICS BIOTECH
Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers. The Company is conducting clinical studies using REOLYSIN®, its proprietary formulation of the human reovirus, in some of the most prevalent forms of the disease including lung, colorectal and pancreatic cancers. Oncolytics’ clinical program includes a number of human trials at a variety of stages including a Phase III trial in head and neck cancers. The Company has advanced its product manufacturing and intellectual property initiatives in parallel with its clinical development program to support development of a commercial product.
Quelle: http://www.oncolyticsbiotech.com/
(Vom Mitglied beendet)